Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision

Affiliations

• ¹ School of Medicine, Oregon Health & Science University, Portland, Oregon.
• ² Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
• ³ Department of Dermatology, University of Washington, Seattle, Washington.
• ⁴ Department of Dermatology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.
• ⁵ Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.
• ⁶ Division of Dermatology, UA Cancer Center Skin Cancer Institute, College of Medicine, University of Arizona, Tucson, Arizona.
• ⁷ Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
• ⁸ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
• ⁹ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Dermatology Section, VA Boston Healthcare System, Jamaica Plain, Massachusetts.
• ¹⁰ Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Melanoma and Skin Cancer Program, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
• ¹¹ Department of Dermatology, Duke University, Durham, North Carolina; Division of Dermatology, Durham VA Medical Center, Durham, North Carolina.
• ¹² Department of Dermatology and Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California.
• ¹³ Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Melanoma and Skin Cancer Program, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Dermatology Section, Operative Care Division, Portland VA Medical Center, Portland, Oregon. Electronic address: yuwe@ohsu.edu.